Diarrhea-predominant irritable bowel syndrome: creation of an electronic version of a patient-reported outcome instrument by conversion from a pen-and-paper version and evaluation...

por Delgado-Herrera, Leticia, Banderas, Benjamin, Ojo, Oluwafunke, Kothari, Ritesh, Zeiher, Bernhardt
Publicado 2017

Safety and pharmacodynamic dose response of short-term prednisone in healthy adult subjects: a dose ranging, randomized, placebo-controlled, crossover study

por Fleishaker, Dona L., Mukherjee, Arnab, Whaley, Fredrick S., Daniel, Shanthini, Zeiher, Bernhardt G.
Publicado 2016

Cultural adaptation: translatability assessment and linguistic validation of the patient-reported outcome instrument for irritable bowel syndrome with diarrhea

por Delgado-Herrera, Leticia, Lasch, Kathryn, Popielnicki, Ana, Nishida, Akito, Arbuckle, Rob, Banderas, Benjamin, Zentner, Susan, Gagainis, Ingrid, Zeiher, Bernhardt
Publicado 2016

Evaluation and performance of a newly developed patient-reported outcome instrument for diarrhea-predominant irritable bowel syndrome in a clinical study population

por Delgado-Herrera, Leticia, Lasch, Kathryn, Zeiher, Bernhardt, Lembo, Anthony J., Drossman, Douglas A., Banderas, Benjamin, Rosa, Kathleen, Lademacher, Christopher, Arbuckle, Rob
Publicado 2017

825 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole vs Voriconazole in Patients with Invasive Mold Disease (IMD): Outcom...

por Raad, Issam, Mullane, Kathleen M., Selleslag, Dominik, Thompson, George, Neofytos, Dionissios, Shoham, Shmuel, Lee, Misun, Maher, Rochelle, Zeiher, Bernhardt, Marty, Francisco M.
Publicado 2014

1210 A Phase 3, Randomized, Double-Blind, Non-inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE)...

por Patterson, Thomas, Selleslag, Dominik, Mullane, Kathleen, Cornely, Oliver, Hope, William, Lortholary, Olivier, Zeiher, Bernhardt, Maher, Rochelle, Lee, Misun, Huang, Wenmei, Kontoyiannis, Dimitrios
Publicado 2014

824 An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis

por Marty, Francisco M., Perfect, John R., Cornely, Oliver A., Mullane, Kathleen M., Rahav, Galia, Lee, Misun, Ito, Masanori, Maher, Rochelle, Zeiher, Bernhardt, Ostrosky-Zeichner, Luis
Publicado 2014

1211 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE)...

por Kontoyiannis, Dimitrios, Giladi, Michael, Lee, Misun, Nucci, Marcio, Raad, Issam, Bow, Eric, Morrison, Vicki a., Baddley, John, Zeiher, Bernhardt, Maher, Rochelle, Huang, Wenmei, Marr, Kieren a.
Publicado 2014

Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled...

por Fleishaker, Dona L, Garcia Meijide, Juan A, Petrov, Andriy, Kohen, Michael David, Wang, Xin, Menon, Sujatha, Stock, Thomas C, Mebus, Charles A, Goodrich, James M, Mayer, Howard B, Zeiher, Bernhardt G
Publicado 2012